---
title: Thermo_CP_Biologics_Strategy_eBook_Oct2026_LandingPage
description: Explore how leading pharma laboratories are moving beyond simple digitization to build a unified, intelligent ecosystem that transforms raw data into a measurable competitive advantage.
---

[![cpLogo](https://lp.contractpharma.com/hs-fs/hubfs/cpLogo.png?width=512&height=175&name=cpLogo.png "cpLogo")](https://www.contractpharma.com/)

![Thermo Biologics Strategy Hero image](https://lp.contractpharma.com/hs-fs/hubfs/eBooks/CP/Thermo%20Fisher/Biologics%20Strategy/Thermo%20Biologics%20Strategy%20Hero%20image.png?width=1016&height=1362&name=Thermo%20Biologics%20Strategy%20Hero%20image.png "Thermo Biologics Strategy Hero image")

 

 

 

eBook

Building a Better Biologics Strategy

From Cell Line Development to Flexible, Global Manufacturing

 

 

### What’s Inside?

Biologics programs rarely move in a straight line. As molecules advance, sponsors need to make decisions about partners, geography, capacity, scalability, and cell line performance—often before long-term requirements are fully clear. This Thermo Fisher Scientific eBook explores how to build more flexibility and continuity into those decisions, from cell line development and CDMO selection to global manufacturing networks and single-use scale-up. The goal is a biologics strategy that can adapt as a program moves from development toward commercial supply.

**Key insights include:**

- What separates a **strategic partner** from a standard CDMO, and the questions to ask before you sign.
- Choosing between **U.S. and European manufacturing** based on target markets, regulatory strategy, and supply chain resilience.
- Using **single-use technology** to match capacity to demand without committing to scale too early
- Advances in **CHO cell line development** that are improving titer, stability, and speed to IND

👉Download the eBook to build a stronger biologics strategy, from cell line to commercial supply

### Send me the eBook!

Copyright © 2026 Rodman Media. All Rights Reserved.